company background image
CPCI

Kahira Pharmaceuticals & Chemical Industries CASE:CPCI Stock Report

Last Price

ج.م42.21

Market Cap

ج.م630.4m

7D

2.0%

1Y

3.3%

Updated

25 Nov, 2022

Data

Company Financials
CPCI fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends4/6

CPCI Stock Overview

Kahira Pharmaceuticals & Chemical Industries Company manufactures and sells pharmaceutical products in Egypt.

Kahira Pharmaceuticals & Chemical Industries Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kahira Pharmaceuticals & Chemical Industries
Historical stock prices
Current Share Priceج.م42.21
52 Week Highج.م47.90
52 Week Lowج.م34.00
Beta0.21
1 Month Change-3.59%
3 Month Change8.48%
1 Year Change3.33%
3 Year Change33.68%
5 Year Change60.42%
Change since IPO14.89%

Recent News & Updates

Recent updates

Shareholder Returns

CPCIEG PharmaceuticalsEG Market
7D2.0%-3.7%2.6%
1Y3.3%6.5%8.7%

Return vs Industry: CPCI underperformed the EG Pharmaceuticals industry which returned 6.5% over the past year.

Return vs Market: CPCI underperformed the EG Market which returned 8.7% over the past year.

Price Volatility

Is CPCI's price volatile compared to industry and market?
CPCI volatility
CPCI Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement5.6%
10% most volatile stocks in EG Market8.9%
10% least volatile stocks in EG Market3.4%

Stable Share Price: CPCI is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: CPCI's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19622,187Yasser Farghalihttps://www.kahirapharma.com

Kahira Pharmaceuticals & Chemical Industries Company manufactures and sells pharmaceutical products in Egypt. Its products include analgesics antipyretics antirheumatic, antibiotics, antidepressants, antidysenterics and enterostatics, antiemetics, antihistamines, antimalarial, cardiacs vascularetics, dermatologicals, endocrine drugs, gastrointestinal drugs, haemostatics, ophthalmics, oro-dentals, pulmonics, single vitamins, sulfhanamides with trimethoprim, topical analgesic antirhumatics, urinary antiseptics, urologics, vaginetics, inhalation surgical products, nutrients, and vitamins and minerals. The company also manufactures veterinary products; and manufactures pharmaceutical products for underlicense companies.

Kahira Pharmaceuticals & Chemical Industries Company Fundamentals Summary

How do Kahira Pharmaceuticals & Chemical Industries's earnings and revenue compare to its market cap?
CPCI fundamental statistics
Market Capج.م630.38m
Earnings (TTM)ج.م165.74m
Revenue (TTM)ج.م1.11b

3.8x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CPCI income statement (TTM)
Revenueج.م1.11b
Cost of Revenueج.م785.17m
Gross Profitج.م326.95m
Other Expensesج.م161.20m
Earningsج.م165.74m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)11.10
Gross Margin29.40%
Net Profit Margin14.90%
Debt/Equity Ratio0%

How did CPCI perform over the long term?

See historical performance and comparison

Dividends

11.8%

Current Dividend Yield

45%

Payout Ratio